Feasibility and Short-Term Outcomes of Percutaneous Transcatheter Pulmonary Valve Replacement in Small (<30 kg) Children With Dysfunctional Right Ventricular Outflow Tract Conduits

  • Berman D
  • McElhinney D
  • Vincent J
 et al. 
  • 19


    Mendeley users who have this article in their library.
  • 34


    Citations of this article.


BACKGROUND: In 2010, the Melody transcatheter pulmonary valve (TPV) received Food and Drug Administration approval for treatment of dysfunctional right ventricular outflow tract conduits in patients ≥30 kg. Limited data are available regarding use of this device in smaller patients.

METHODS AND RESULTS: We evaluated technical and short-term clinical outcomes of 25 patients
CONCLUSIONS: Percutaneous TPV replacement can be performed in small children with good procedural and early hemodynamic results in the majority of patients.

Author-supplied keywords

  • Cardiac Catheterization
  • Congenital
  • Heart Defects
  • Pulmonary Valve

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Darren P. Berman

  • Doff B. McElhinney

  • Julie A. Vincent

  • William E. Hellenbrand

  • Evan M. Zahn

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free